Nanomedicine

Pradipta Ranjan

Nanomedicine

The advancement of nanotechnology offers a new dimension to tumor-targeting strategies. Nanoparticles are gathering increasing interest for biomedical applications due to their novel properties such as high stability and biological compatibility, controllable morphology and size dispersion, chemical surface functionalization and unique optical or magnetic properties.

Our goal is to develop nanotechnologies and biomolecular engineering approaches for cancer therapeutics. The development of the methodologies involves nanodevice design and validation, synthesis of biomolecules and nanoparticles, specific tagging and targeting, cellular delivery, surface modification, as well as addressing issues such as specificity, sensitivity and spatial and temporal resolution.